AI-driven design and automation, built for discovery
Breakthrough AI innovation
We make industry-leading multimodal AI technologies, built for the purpose of drug discovery
The multimodal transformer for drug discovery
Enchant is a state-of-the-art multimodal transformer model that learns from small, noisy data sets to make informative predictions across a large array of biochemical and cellular activities, and for a wide range of target classes. Enchant breaks through the “data wall” between preclinical discovery and clinical development.
New molecular designs to new biological data each week
New molecular designs to new biological data each week
Parallel testing across alternative profiles based on platform-generated biological insights
De novo protein-ligand structure and cryptic pocket prediction
Nanoscale synthesis of thousands of unique compounds per week
Generating biochemical, metabolic, and cellular data
Automated data pipelines and model retraining, every week
Creating the right molecule for the right profile
By identifying diverse chemical matter with unique profiles, we arrive at highly differentiated development candidates selected from multiple strong lead series
Publications
Learn more about the technology that drives our platform
A Phase 1/1b Study of IAM1363, a selective and brain penetrant HER2 inhibitor in participants (pts) with advanced cancers harboring HER2 alterations
A Phase 1/1b Study of IAM1363, a selective and brain penetrant HER2 inhibitor in participants (pts) with advanced cancers harboring HER2 alterations
IAM1363 is a Potent, Selective, and Irreversible HER2 and Pan-HER2 Mutant Small Molecule Inhibitor for the Treatment of HER2-Driven NSCLC
